Case Control Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Feb 28, 2019; 25(8): 967-979
Published online Feb 28, 2019. doi: 10.3748/wjg.v25.i8.967
Table 2 Comorbidities n (%)
ComorbidityDrug-induced colitis, n = 211Non-inflammatory controls, n = 211Inflammatory controls, n = 211
Pulmonary39 (18.5)31 (14.7)37 (17.5)
Cardiac110 (52.1)93 (44.1)87 (41.2)
Neurological27 (12.8)23 (10.9)19 (9.0)
Psychiatric10 (4.7)9 (4.3)10 (4.7)
Endocrine47 (22.3)44 (20.9)30 (14.2)
Renal28 (13.2)18 (8.5)21 (10.0)
Hepatic11 (5.2)13 (6.2)11 (5.2)
Oncological14 (6.6)25 (11.8)17 (8.1)
Other19 (9.0)15 (7.1)16 (7.6)
Heart failure35 (16.6)16 (7.6)b231 (14.7)a3
Renal insufficiency24 (11.4)14 (6.6)18 (8.5)
Atrial fibrillation26 (12.3)18 (8.5)22 (10.4)
Coronary heart disease47 (22.3)28 (13.3)a235 (16.6)
Peripheral arterial occlusive disease7 (3.3)10 (4.7)11 (5.2)
Atherosclerosis74 (35.1)b139 (18.5)b240 (19.0)
Arterial hypertension98 (46.4)97 (46.0)87 (41.2)
Diabetes mellitus46 (21.8)45 (21.3)32 (15.2)
Hypercholesterinaemia20 (9.5)16 (7.6)18 (8.5)
Hyperlipoproteinaemia22 (10.4)a111 (5.2)a29 (4.3)
Chronic obstructive lung disease29 (13.7)24 (11.4)27 (12.8)
Stroke14 (6.6)9 (4.3)11 (5.2)
Smoking77 (36.7)66 (31.3)78 (37.0)
Surgery9 (4.3)1 (0.5)a23 (1.4)
Intensive care therapy9 (4.3)2 (0.9)a24 (3.1)